Kohvakka A, Hussi E
J Int Med Res. 1986;14(4):188-92. doi: 10.1177/030006058601400404.
The diuretic and potassium- and magnesium-conserving action of a single dose of frusemide/triamterene, F + TRI (40 mg/50 mg), and hydrochlorothiazide/amiloride, HCT + AMI (50 mg/5 mg), fixed combination preparations were compared in ten healthy adults in a randomised double-blind placebo-controlled study. Urinary volume during 24 hours was significantly higher after HCT + AMI ingestion than after F + TRI. The urine and sodium excretions caused by HCT + AMI lasted markedly longer and were smoother than the short and somewhat unpleasant effects of F + TRI. HCT + AMI also spared potassium and magnesium relatively more effectively than F + TRI.
在一项随机双盲安慰剂对照研究中,对10名健康成年人比较了单剂量速尿/氨苯蝶啶(F + TRI,40毫克/50毫克)和氢氯噻嗪/阿米洛利(HCT + AMI,50毫克/5毫克)固定复方制剂的利尿以及保钾和保镁作用。摄入HCT + AMI后24小时的尿量显著高于摄入F + TRI后。HCT + AMI引起的尿液和钠排泄持续时间明显更长且更平稳,而F + TRI的作用短暂且有点不适。HCT + AMI在保钾和保镁方面也比F + TRI更有效。